Trulieve: Canaccord Retains $97 Price Target Following Harvest Health Transaction

On October 1, Trulieve Cannabis (CSE: TRUL) announced that they completed their $1.75 billion acquisition of Harvest Health (CSE: HARV). Harvest shareholders received 0.1170 shares of Trulieve for each subordinate voting share held. Trulieve issued a total of 50.9 million shares. The pro-forma second quarter revenue would have been $317.6 million.

A number of analysts raised their 12-month price targets off the back of the completed acquisition. This brought the average 12-month price target up to C$84.80, or a 137% upside. There are 17 analysts covering the stock, with 5 analysts having strong buy ratings and the other 12 have buy ratings. The street high sits at C$132 from Stifel-GMP while the lowest comes in at C$54.

In Canaccord’s note, they elected to just revise their estimates while keeping their Buy rating and C$97 price target the same. They say that beyond the attractive assets in Florida and Arizona, Pennsylvania is one of the key reasons why they like this transaction. They write, “Florida and Pennsylvania also offer potential significant adult-use upside beyond what we have included in our estimates.”

Canaccord also commends Trulieve on raising $350 million at 8% with no warrant, saying that this has been the most attractive term in the space. This, combined with the $55 million they got from selling Harvest’s Florida license, makes Trulieve’s balance sheet “well-positioned to fund organic growth in these key markets.” Canaccord believes that it will use its balance sheet to focus on its adult-use markets, specifically Arizona and Massachusetts as well as keeping its eyes out for acquisitions.

Below you can see Canaccord’s updated 2021 and 2022 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Is Gold’s Bull Market About to Hit Junior Stocks? | Ken Armstrong – Westhaven Gold

Surge Battery Metals: The Nevada North Lithium PEA

Silver @ $36 & We’re Still 200M Oz Short | Paul Andre Huet – Americas Gold and Silver

Recommended

Goliath Resources Closes Out Funding Round With Total Gross Proceeds Of $27.1 Million

Silver47 Kickstarts 4,000 Metre Drill Campaign At Red Mountain Project

Related News

Netflix: Analysts Downgrade En Masse Following Weak Subscriber Growth

Last night Netflix (NASDAQ: NFLX) reported their quarterly earnings, which financially, came generally in line...

Wednesday, April 21, 2021, 04:03:00 PM

Aphria: Consensus Estimates For Q3 2021

Aphria Inc (TSX: APHA) (NASDAQ: APHA) is expected to report their fiscal third quarter on...

Wednesday, April 7, 2021, 02:41:00 PM

Tilray & Aphria: The Analyst Perspective

This morning it was announced that Aphria Inc (TSX: APHA) (NASDAQ: APHA) and Tilray Inc...

Wednesday, December 16, 2020, 02:04:02 PM

Hexo: Canaccord Raises Price Target To $1.25 Following Q1 Results

Yesterday, Hexo Corp (TSX: HEXO) (NYSE: HEXO) released its fiscal first quarter 2021 financial results....

Tuesday, December 15, 2020, 11:05:36 AM

Canaccord Reiterates $10 Price Target On Blackberry Following Results

On September 22, BlackBerry Limited (TSX: BB) reported their second quarter financial results for the...

Friday, September 24, 2021, 10:52:00 AM